Background {#Sec1}
==========

Osteonecrosis (ON) is a serious disease that causes joint pain and significant physical disability. Various joints can be affected, including the shoulders, knees, and ankles, but the most commonly affected site is the hip \[[@CR1], [@CR2]\]. Although the detailed pathogenesis of ON remains unclear, ON may reflect bony ischemia caused by direct injury or vascular damage \[[@CR3]\]. Trauma, excessive alcohol intake, corticosteroid treatment, and rheumatic and malignant diseases contribute to the development of ON \[[@CR4]\]. Multifocal ON, which ON involves three or more distinct anatomical sites \[[@CR5]\], is rare, being seen in only approximately 3% of all ON patients \[[@CR5]\]. Corticosteroid use is a known risk factor for multifocal ON \[[@CR5], [@CR6]\], as are certain comorbidities, including systemic lupus erythematosus (SLE), renal failure, leukemia, and lymphoma \[[@CR5], [@CR7], [@CR8]\]. However, almost all studies of multifocal ON are case reports and case series, so the incidence and clinical characteristics of the condition remain poorly defined \[[@CR5], [@CR8]--[@CR13]\].

Imaging is used to diagnose ON and evaluate the severity of lesions. Radiographs are often used initially, but early-stage disease may not be detected because radiographic abnormalities develop only after prolonged ischemic change \[[@CR14]\]. Magnetic resonance imaging (MRI) detects ON with high sensitivity and is used to assess the severity of the disease \[[@CR15]\]. However, routine MRI does not cover all joints because of the high cost. A whole-body bone scan (WBBS) is more sensitive than a simple X-ray in terms of diagnosing ON \[[@CR16]--[@CR18]\]. A WBBS can be used to screen for multifocal ON, revealing abnormal bone uptake of Tc-99 phosphates \[[@CR19]\]. However, bone scintigraphy is of low sensitivity when used to diagnose symptomatic ON \[[@CR1]\]. Although several studies have reported bone scan data for ON patients, the results are inconsistent and limited to case reports or case series with small numbers of patients \[[@CR1], [@CR16]--[@CR19]\].

Therefore, we retrospectively reviewed the medical records of ON patients and their WBBS, X-ray, and MRI data; identified those with multifocal ON; and investigated the clinical characteristics and utility of WBBS in patients with multifocal ON.

Methods {#Sec2}
=======

Subjects {#Sec3}
--------

We identified 294 patients among the computerized medical records held at Ajou University Hospital with the diagnostic code for ON and test code for WBBS; 40 patients were excluded because their diagnosis was not confirmed to ON and MRI findings were negative. We retrospectively reviewed data on 254 patients with ON confirmed by MRI or X-ray of the site at the time of their initial visit between 2003 and 2017. We reviewed the WBBS and the MRI or X-rays of the sites, such as hips, knees, ankles and shoulders. We divided the patients into multifocal and oligofocal ON groups. Multifocal ON was defined as ON involving three or more separate anatomical sites, as described previously \[[@CR5]\]. A total of 26 patients diagnosed with multifocal ON were compared to the 228 remaining patients with a diagnosis of oligofocal ON. The study was approved by our institutional review board (approval no. AJIRB-MED-MDB-18-041).

Variables {#Sec4}
---------

All clinical data were retrieved from medical records stored in the hospital database. Age, sex, all comorbidities, clinical symptoms and their duration, and previous treatment were recorded at the time of WBBS. The cumulative corticosteroid dose (prednisolone equivalent for all oral, intravenous, subcutaneous, and intramuscular administrations) during the WBBS was calculated. Excessive alcohol intake was defined as consumption of more than 400 mL of alcohol per week. Soju is a distilled Korean liquor; one bottle of Soju contains 72 mL of alcohol (i.e., 360 mL containing 20% alcohol). Therefore, excessive alcohol intake can be defined as consumption of one bottle of Soju per day, or two bottles of Soju on 3 or more days per week. We divided the causes of ON into four categories: 1) idiopathic, 2) trauma, 3) a comorbidity requiring the use of corticosteroids or immunosuppressive agents, and 4) excessive alcohol intake.

WBBS acquisition {#Sec5}
----------------

WBBS was performed 4 h after injection of 740 MBq technetium-99 m hydroxymethylene diphosphonate (Tc-99 m HDP). Anterior and posterior views were acquired using a double-headed gamma camera equipped with a VariCam Millennium VG low-energy high-resolution collimator (GE Medical Systems, Milwaukee, WI, USA). Images were analyzed on a Xeleris Workstation (GE Healthcare, Buckinghamshire, UK).

WBBS image interpretation and analysis {#Sec6}
--------------------------------------

All WBBSs were analyzed visually by a specialist in nuclear medicine, with 14 years of experience (Y.S.A.), blind to all other clinical data. Bone regions exhibiting uptake were recorded, and the extent of the uptake was graded visually from 0 to 2 (0 = no uptake, 1 = mild, 2 = intense). In addition, uptake was recorded as bilateral or unilateral. Photon defects were also noted.

Simple radiographs and MRI {#Sec7}
--------------------------

Simple radiographs and MR images were obtained using standard imaging protocols featuring at least two projections or planes. MR imaging was performed using a 1.5-T (Signa HDxt, Signa Excite; GE Healthcare) or a 3 T (Achieva; Philips Healthcare, Best, The Netherlands) system fitted with commercial body or extremity coils depending on the location of the lesion. All sequences included fat-saturated T2-weighted and T1-weighted images (non-contrast T1 and fat-suppressed contrast-enhanced T1 images).

Simple radiograph and MR image interpretation and analysis {#Sec8}
----------------------------------------------------------

A musculoskeletal radiologist with 10 years of experience (S.P.), blind to the clinical information evaluated simple radiographs and MR images. On a simple radiograph, ON was defined as a combination of sclerosis, cystic change, and a crescent-shaped, subchondral, lucent lesion \[[@CR20]\]. On an MR image, a band-like, crescent-shaped, or sector-like region of bone marrow replacement and the double-line sign (an inner line of high signal intensity running parallel to an outer line of low signal intensity) were considered diagnostic of ON, which was classified using the Association Research Circulation Osseous (ARCO) system \[[@CR21]\].

Statistical analyses {#Sec9}
--------------------

All statistical analyses were performed using SPSS software (ver. 23.0; SPSS Inc., Chicago, IL, USA). *p* \< 0.05 was considered to reflect statistical significance. Results are presented as means ± standard deviation (SD) for continuous variables and as frequencies with percentages for categorical variables. Independent Student's t-test was used to compare continuous variables, and Pearson's chi square test was used to compare categorical variables. Factors associated with multifocal ON were defined using logistic regression. The extent of the agreement between WBBS and hip MRI or X-ray images was evaluated using the kappa (κ) statistic; κ \>  0.8 represents excellent agreement, 0.61--0.8 good agreement, 0.41--0.6 moderate agreement, 0.21--0.4 fair agreement, and \< 0.2 poor agreement \[[@CR22]\].

Results {#Sec10}
=======

Clinical characteristics of patients with multifocal and oligofocal ON {#Sec11}
----------------------------------------------------------------------

Table [1](#Tab1){ref-type="table"} lists the clinical characteristics of the 254 patients with ON confirmed by MRI or X-ray. Their mean age was 50.0 ± 15.4 years, and 152 (59.8%) were male. A total of 26 patients (10.2%) had multifocal ON as shown by WBBS and MRI or X-ray. Twenty-four patients had multifocal ON evident on WBBS and MRI or X-ray. In the other two patients, multifocal ON was confirmed by multifocal site evaluation by MRI or X-rays, with negative results on WBBS. The mean age of patients with multifocal ON (42.8 ± 14.3 years) was less than that of patients with oligofocal ON (50.9 ± 15.4 years; *p* = 0.011). Accompanying comorbidities were more common in patients with multifocal ON (*n* = 18, 69.2%) than oligofocal ON (*n* = 91, 39.9%; *p* = 0.006). Current corticosteroid use was more common in those with multifocal ON (16, 61.5%) than oligofocal ON (50, 21.9%; *p* \< 0.001). However, cumulative corticosteroid dose did not differ between the groups (*p* = 0.859). Immunosuppressive agents were more commonly taken by patients with multifocal ON (11, 42.3%) than oligofocal ON (40, 17.5%; *p* = 0.007). Table [2](#Tab2){ref-type="table"} lists the causes of ON. The most common cause of multifocal ON was a comorbidity requiring the use of corticosteroids or immunosuppressive agents (18, 69.2%); the other causes were idiopathic (4, 15.4%), alcohol intake (3, 11.5%), and trauma (1, 3.8%). The most common cause of oligofocal ON was excessive alcoholic intake (74, 32.5%), followed by a comorbidity requiring the use of corticosteroids or immunosuppressive agents (70, 30.7%), idiopathic causes (60, 26.3%), and trauma (24, 10.5%). The most common cause of ON thus differed for multifocal and oligofocal ON (*p* = 0.001). Table [3](#Tab3){ref-type="table"} lists the comorbidities in all patients. Figure [1](#Fig1){ref-type="fig"} shows ON sites confirmed by WBBS and MRI or X-rays in all 254 patients.Table 1Clinical characteristics of multifocal and oligofocal osteonecrosis (ON) in 254 patients with ONMultifocal ON\
(*n* = 26)Oligofocal ON\
(*n* = 228)Any ON\
(*N* = 254)*p*-valueAge (years)42.8 ± 14.350.9 ± 15.450.0 ± 15.40.011Sex (M/F)15 (57.7)/11 (42.3)137 (60.1)/91 (39.9)152 (59.8)/102 (40.2)0.835Smoking (yes)7 (26.9)94 (41.2)101 (39.8)0.205Alcohol use (excessive)10 (38.5)104 (45.6)114 (44.9)0.538Diabetes mellitus3 (11.5)11 (4.8)14 (5.5)0.162Hypertension10 (38.5)54 (23.7)64 (25.2)0.150Trauma1 (3.8)37 (16.2)38 (15.0)0.007Symptom sites (n)1.92 ± 1.261.26 ± 0.441.33 ± 0.610.014Symptom duration (months)7.0 ± 9.37.5 ± 13.77.4 ± 13.30.855Comorbidity18 (69.2)91 (39.9)109 (42.9)0.006Comorbidity duration (years)6.37 ± 6.776.74 ± 6.806.68 ± 6.770.833Use of CS16 (61.5)50 (21.9)66 (26.0)\< 0.001Maximal dose of CS284.4 ± 427.3154.0 ± 317.0185.6 ± 347.90.273Cumulative dose of CS5310.7 ± 5359.65704.8 ± 7664.75612.8 ± 7153.00.859Use of immunosuppressive agents11 (42.3)40 (17.5)51 (20.1)0.007Osteoporosis1 (3.8)12 (5.3)13 (5.1)\>  0.999Use of BP1 (3.8)10 (4.4)11 (4.3)\>  0.999BP duration (months)2449.7 ± 18.547.4 ± 19.2ON sites confirmed by X-ray and MRI3.04 ± 1.421.52 ± 0.531.68 ± 0.81\< 0.001ON sites confirmed by bone scan4.15 ± 2.051.27 ± 0.531.57 ± 1.20\< 0.001*ON* osteonecrosis, *CS* corticosteroid, *BP* bisphosphonate, *MRI* magnetic resonance imaging. All values are presented as numbers (%) or means ± SD. Independent Student's *t*-test was used to compare continuous variables, and Pearson's chi square test was used to compare categorical variables between multifocal and oligofocal ONTable 2Causes of multifocal and oligofocal osteonecrosis (ON) in patients with ONCause of ONMultifocal ON\
(*n* = 26)Oligofocal ON\
(*n* = 228)Any ON\
(*N* = 254)*p*-valueIdiopathic4 (15.4)60 (26.3)64 (25.2)0.001Trauma1 (3.8)24 (10.5)25 (9.8)Comorbidity requiring corticosteroids and immunosuppressive agents18 (69.2)70 (30.7)88 (34.6)Excessive alcohol intake3 (11.5)74 (32.5)77 (30.3)*ON* osteonecrosis. Pearson's chi square test was used to compare causes of multifocal and oligofocal ONTable 3Comorbidities in patients with multifocal and oligofocal osteonecrosis (ON)ComorbidityMultifocal ON\
(*n* = 18/26)Oligofocal ON\
(*n* = 70/228)Any ON\
(*N* = 88/254)**Immune system disease82634** Ulcerative colitis11 Rheumatoid arthritis55 AOSD11 Systemic lupus erythematosus3710 MCD, MGN, IgA nephropathy279 ANCA-associated vasculitis112 Dermatomyositis33 Sarcoidosis, Behçet's disease, vitalism123**ESRD with KT369Malignancy21618** Lung cancer11 Stomach cancer123 Renal cancer22 Breast cancer156 Neuroblastoma22 Rectal cancer22 Gall bladder cancer11 Hepatocellular carcinoma11**Hematological diseases44** Acute myelocytic leukemia11 Multiple myeloma11 Aplastic anemia22**Mitral valve stenosis, with operation11Spinal cord tumor, meningioma, pheochromocytoma123Craniopharyngioma, seizure112Osteoporosis with bisphosphonate treatment22Bronchiectasis11Facial palsy, hearing loss, trigeminal neuralgia123Recurrent oral ulcer, recurrent uveitis112Allergic disease (urticarial, Steven-Johnson), vitalism, asthma156Liver cirrhosis, intraperitoneal bleeding33***ON* osteonecrosis, *AOSD* adult onset Still's disease, *MCD* minimal change disease, *MGN* membranous glomerulonephritis, *ANCA* anti-neutrophil cytoplasmic antibody, *ESRD* end-stage renal disease, *KT* kidney transplantationFig. 1**a** Osteonecrosis (ON) sites confirmed by whole body bone scan (WBBS) and magnetic resonance imaging (MRI) or X-ray in 254 patients with ON. **b** ON sites confirmed by WBBS and MRI or X-ray in 26 patients with multiple ON. Local MRI was obtained for 419 sites and X-ray images of 415 sites were obtained in the 254 patients with ON. Overall, WBBS images of 477 sites were compared with local MR or X-ray images

Factors associated with multifocal ON {#Sec12}
-------------------------------------

We evaluated factors associated with multifocal ON (Table [4](#Tab4){ref-type="table"}). Age (odds ratio \[OR\] = 0.964, *p* = 0.013), comorbidity (OR = 3.387, *p* = 0.006), corticosteroid use (OR = 5.696, *p* \< 0.001), and treatment with immunosuppressive agents (OR = 3.447, *p* = 0.004) were significantly associated with multifocal ON in univariate analyses. Age (OR = 0.967, 95% confidence interval \[CI\]: 0.940--0.994, *p* = 0.017) and comorbidity (OR = 2.674, 95% CI: 1.033--6.922, *p* = 0.043) were significantly associated with multifocal ON in a multivariate logistic regression that also evaluated alcohol intake and trauma. Corticosteroid use (OR = 4.512, 95% CI: 1.702--11.964, *p* = 0.002) was significantly associated with multifocal ON in a multivariate logistic regression that also included alcohol intake, trauma, and corticosteroid use. However, only age (OR = 0.969, 95% CI: 0.941--0.997, *p* = 0.028) was associated with multifocal ON in multivariate analyses that included age, alcohol intake, trauma, and the use of immunosuppressive agents. Figure [2](#Fig2){ref-type="fig"} shows the WBBS, MRI, and X-ray of a case of multifocal ON.Table 4Logistic regression analyses of factors associated with multifocal osteonecrosis (ON) in patients with ONClinical factorUnivariate*p*-valueMultivariate*p*- valueMultivariate*p*- valueOR95% Wald CIOR95% Wald CIOR95% Wald CIAge0.9640.9370.9920.0130.9670.9400.9940.0170.9780.9501.0080.149Alcohol abuse0.7450.3241.7120.4880.8940.3602.2190.8101.1310.4382.9170.799Trauma history0.2060.0271.5710.1280.2730.0342.1880.2730.2570.0332.0240.197Comorbidity3.3871.4138.1180.0062.6741.0336.9220.043--Use of corticosteroids5.6962.43413.328\< 0.001--4.5121.70211.9640.002Use of immunosuppressive agents3.4471.4748.0610.004----*ON* osteonecrosisFig. 2A 42-year-old male case of multifocal osteonecrosis (ON). **a** This is a bone scintigraphy performed in a 42-year-old male patient with abnormal photon-defects in both femoral heads (long arrows). Also abnormal hot uptakes were also observed in the left humeral head (white arrow), both distal femoral (short arrows) and proximal tibial regions (arrowheads), suggesting that AVN is suspected. **b** Pelvis anteroposterior view (AP) shows radiolucency and surrounding sclerosis of both femoral heads (arrows). **c** Coronal T1-weighted image shows large areas of low signal intensity demonstrated typical band-like pattern of ON involving both femoral heads (arrows). **d** Both knee AP views show ill-defined lucency and sclerosis with cyst like appearance of both distal femur and proximal tibia. **e** Coronal T1-weighted image shows multiple geographic lesions with peripheral low signal intensity of rim involving both distal femur and proximal tibia. **f** Simple radiographs show more advanced degree of ON with subchondral fracture and mild osteoarthritic change involving left humeral head (arrow)

WBBS, MRI, and X-ray results {#Sec13}
----------------------------

Both WBBS and local MRI images were obtained for 458 sites, and 456 sites were evaluated with WBBS and X-ray images among the 294 patients who underwent WBBS with a code of ON. Therefore, a total of 458 sites were compared based on WBBS and MR images, and 456 were compared based on WBBS and X-ray images (Table [5](#Tab5){ref-type="table"}). WBBS was positive for 346 sites (75.5%), and the MRI for 419 (91.4%). Of the 458 sites, WBBS and MRI were in agreement for 369. The κ coefficient of agreement between WBBS and MRI data was fair (κ = 0.325, *p* \< 0.001). WBBS was positive for 348 (76.3%) of the 456 sites, and the X-rays for 326 (71.4%). Of the 456 sites, WBBS and X-rays were in agreement for 362. The coefficient of agreement was moderate (κ = 0.467, *p* \< 0.001).Table 5Agreement between whole-body bone scan (WBBS) data and magnetic resonance imaging (MRI) and X-ray data in patients with osteonecrosis (ON)ON confirmed by bone scanTotal(−)(+)ON confirmed by MRI(−)31 (6.8)8 (1.7)39(+)81 (17.7)338 (80.7)419Total112346458ON confirmed by X-ray(−)72 (15.8)58 (12.7)130(+)36 (11.0)290 (63.6)326Total108348456κ = 0.325 between bone scan and MRI (*p* \< 0.001); κ = 467 between bone scan and X-ray (*p* \< 0.001)

We explored possible associations between WBBS uptake grade/defects and the ARCO classification, as determined by MRI (Table [6](#Tab6){ref-type="table"}). The uptake grade was associated with the ARCO classification (*r* = 0.491, *p* \< 0.001), but uptake defects were not (*r* = − 0.032, *p* = 0.496).Table 6Associations between uptake grade of, or defect evident on, whole-body bone scan (WBBS) and Association Research Circulation Osseous (ARCO) classifications on magnetic resonance imaging (MRI)ARCOUptake grade of WBBSTotal*p*-valueWBBS Photon defectTotal*p*-value012(−)(+)0325239**0.491,**\
**\< 0.001**53439−0.032,\
0.4961301117581444582546669189801091893933101143391041434092029101929Total125124209458148310458*WBBS* whole-body bone scan, *ARCO* Association Research Circulation Osseous

Discussion {#Sec14}
==========

We found that 10.2% of ON patients had multifocal ON associated with younger age, comorbidities, and the use of corticosteroids and immunosuppressive agents. Agreement between WBBS and MRI for all patients was fair, but the agreement between WBBS and X-rays was moderate. The ARCO score was significantly associated with the WBBS uptake grade.

Trauma and nontraumatic factors (excessive alcohol intake, corticosteroid use, and HIV infection) cause ON \[[@CR2], [@CR3]\]. Corticosteroid and alcohol use are responsible for more than 90% of all cases of ON \[[@CR3]\]. Other causes include hypercoagulable conditions and radiation therapy \[[@CR23]\]. We classified the causes of ON into four categories: idiopathic, trauma, comorbidities requiring the use of corticosteroids or immunosuppressive agents, and excessive alcohol intake. The principal causes were excessive alcohol intake (30.3%) and comorbidities requiring corticosteroid and/or immunosuppressive treatment (34.6%), similar to what was found in previous studies. Comorbidities included several diseases of the immune system, including SLE, dermatomyositis, and ulcerative colitis; malignancy; kidney transplantation to treat end-stage renal disease; and hematological conditions. We also included benign conditions requiring corticosteroids (aphthous ulcer, recurrent uveitis, facial palsy, and several allergic diseases) as comorbidities.

Multifocal ON is uncommon,being observed in only 3--11% of ON patients \[[@CR5]\]. It was associated in several case studies and case reports with high-dose corticosteroid therapy, high alcohol intake, several immune system diseases (including SLE), organ transplantation, and malignancy \[[@CR6], [@CR8], [@CR9], [@CR12], [@CR24]\]. Earlier studies were (prospective or retrospective) observational studies performed during treatment and follow-up in patients with sickle-cell disease, acute lymphocytic leukemia, and non-Hodgkin disease \[[@CR25]--[@CR27]\]. The incidence of multifocal ON was 44--82%. In this study, we did not evaluate the development of ON in patients at risk; rather, we found on review that 10.2% of 254 ON patients had multifocal ON as evidenced by WBBS and MR or X-ray images. Their mean age (42.8 ± 14.3 years) was less than that of patients with oligofocal ON (50.9 ± 15.4 years; *p* = 0.011). Furthermore, the most common causes of multifocal ON differed from those of oligofocal ON. Most former patients (69.2%) had comorbidities including systemic immune diseases, had undergone kidney transplantation, or had malignancies. Three patients consumed alcohol excessively, one patient had experienced severe trauma, and the causes of ON in four patients were unknown. We found that younger age, comorbidity, and use of corticosteroids and immunosuppressive agents were associated with multifocal ON. Several studies found that corticosteroid treatment, various rheumatic diseases, and hematological disease were so associated \[[@CR5], [@CR8], [@CR11]\]. We derived ORs for the relevant factors: current corticosteroid use alone was highly significant in this context (OR = 4.512), but neither the cumulative nor maximal dose of corticosteroids differed between those with multifocal and oligofocal ON.

Conventional MRI is the most sensitive and specific imaging modality for early diagnosis and evaluation of ON progression \[[@CR15]\]. However, the cost is high, and it is not yet covered by national health insurance in Korea. MRI can be used to evaluate one or two symptomatic lesions, but not all symptom-free areas can be examined, even if multifocal ON is suspected. A recent study assessed the utility of coronal, short-tau inversion recovery, whole-body MRI (STIR-WBMI) for evaluating ON in 15 patients with myositis \[[@CR28]\]; STIR-WBMRI detected early multifocal ON. However, further studies with larger populations are needed. A recent study used whole-body MRI to evaluate 42 patients with Hodgkin lymphoma treated by chemotherapy. Of the 48 osteonecrotic lesions observed, 48% were detected in the knees, and multifocal ON was detected in six of seven patients (86%) \[[@CR29]\]. Furthermore, the metadiaphysis was involved more frequently than the epiphysis (40% vs. 33%). As a result, whole-body MRI could be a very helpful tool for early detection of multifocal osteonecrotic lesions, but it is also expensive and is not yet covered by national health insurance in Korea. WBBS may be useful for diagnosing ON \[[@CR16], [@CR30]\]. WBBS is relatively inexpensive, and is easier to perform than MRI. However, several recent studies found that MRI was more sensitive \[[@CR15], [@CR31]\]. Another study found that WBBS was less sensitive than MRI for diagnosing symptomatic ON \[[@CR1]\]. Although all 163 patients with histologically confirmed lesions were identified by MRI, only 56% were confirmed by WBBS. In our study, the extent of agreement between MRI and WBBS data was fair (κ = 0.325). However, 346 of 419 MRI-identified lesions were confirmed by WBBS (80.7%). Furthermore, the ARCO classification was significantly associated with femoral bone uptake grade on WBBS. In addition, WBBS identified 24 of 26 patients with multifocal ON (92.3%). Therefore, WBBS may be an additional tool for diagnosing ON and assessing its progression, especially in patients with suspected multifocal ON.

Our study has several limitations. First, this was a retrospective cross-sectional work. Second, we lacked bone biopsy data and instead used MRI or X-ray data to locate affected sites. Third, in patients with multifocal ON, not all ON sites were evaluated using MRI or X-ray. Fourth, selection bias may have been in play; we reviewed medical records. Corticosteroids are a major cause of ON. Therefore, patients treated with corticosteroids may undergo more WBBS than those not treated with corticosteroids, which may have resulted in selection bias in this study. Fourth, the ON sites were not evaluated according to the lesion location, such as the metadiaphyseal or epiphyseal regions, as described previously \[[@CR29]\]. However, most lesions of the patients with ON were located in epiphyseal regions, and only seven patients had metadiaphyseal ON without epiphyseal ON. Twenty-three patients with ON had metadiaphyseal and epiphyseal ON. This was probably due to MRI being expensive in Korea, so that only the symptomatic sites were evaluated. However, this is the first study to calculate ORs for the risks associated with corticosteroid therapy and comorbidities in terms of multifocal ON, and to correlate quantitative bone scan data with the MRI ARCO classification of femoral head ON, which is representative of epiphyseal ON, in patients with ON. Our findings suggest that WBBS could play a useful role in the evaluation of multifocal ON.

Conclusions {#Sec15}
===========

Multifocal ON is not uncommon. Age, comorbidity, and use of corticosteroids and immunosuppressive agents were significantly associated with multifocal ON. The ARCO classification correlated significantly with the bone uptake grade but not with photon defects. WBBS may be an additional tool for evaluating ON patients with risk factors for multiple ON, such as younger age, corticosteroid use, and comorbidities.

ARCO

:   Association Research Circulation Osseous

MRI

:   Magnetic resonance imaging

ON

:   Osteonecrosis

SD

:   Standard deviations

SLE

:   Systemic lupus erythematosus

STIR-WBMI

:   Short-tau inversion recovery, whole-body MRI

Tc-99 m HDP

:   Technetium-99 m hydroxymethylene diphosphonate

WBBS

:   Whole-body bone scan
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